Scientific Global Co-Founder and Partner, Kerri Riccardo, Announced as an MM+M 2025 Women of Distinction Honoree

June 12, 2025 08:54 AM AEST | By EIN Presswire
 Scientific Global Co-Founder and Partner, Kerri Riccardo, Announced as an MM+M 2025 Women of Distinction Honoree
Image source: EIN Presswire

NEW YORK, NY, UNITED STATES, June 11, 2025 /EINPresswire.com/ -- Medical Marketing & Media (MM+M) celebrated its 2025 Women of Distinction honorees on June 3 in New York City at The Lighthouse at Chelsea Piers. Now in its 10th year, the MM+M Women of Distinction program recognizes healthcare marketing executives who have significantly impacted their organizations during the past year.

Kerri Riccardo is a Co-Founder and Partner at Scientific Global (SG), where she spearheads the development of bold, innovative market expansion strategies that drive measurable results. Renowned for her visionary leadership, Kerri was among the first to recognize the vital role Nurse Practitioners play in patient health and well-being, proactively championing their needs through MedComms initiatives. “Kerri brings creativity, entrepreneurial spirit, and genuine compassion to everything she does,” notes her business Partner, Jennifer Rudolph. With experience spanning hundreds of brands across nearly every therapeutic area—including rare diseases, broad portfolios, and blockbuster products—Kerri’s expertise and passion continue to shape the industry.

"Medical marketing stands out as an industry where women are leading the charge," said Lecia Bushak, editor of pharma at MM+M. "For the 10th year in a row, we've been highlighting the extraordinary work of women who are driving creativity and innovation in the industry, as well as shaping the future of healthcare."

The 2025 Women of Distinction honorees will be featured in the July-August print edition of MM+M.

About Scientific Global
Scientific Global (SG) is a promotional, female-owned and operated MedComms agency based in New York, with offices in London and Toronto. Structured to move brands forward, SG is laser-focused on amplifying the power of MedComms to accelerate the adoption of transformational products, devices, and diagnostics for the people who need them most.

About MM+M
(Medical Marketing + Media) is the premier media brand covering pharmaceutical marketing and commercialization. Since 1966, MM+M has delivered trusted, timely content through breaking news, in-depth analysis, monthly print features, and award-winning podcasts. Reaching an executive audience across pharma, medical devices, diagnostics, and health marketing, MM+M is the industry's go-to source for insights, trends, and best practices that help healthcare marketers thrive.

Jennifer Rudolph
Scientific Global
[email protected]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.